The latest OVATION-2 trial update, presented at the American Society of Clinical Oncology 2025 annual meeting, shows that adding intraperitoneal IMNN-001 to standard neoadjuvant chemotherapy improved both...
A phase II trial evaluating pembrolizumab plus lenvatinib in clear cell ovarian carcinoma shows promising response rates and 6-month progression-free survival.
A retrospective analysis from Memorial Sloan Kettering links higher patient-reported pain to increased emergency department utilization among individuals newly diagnosed with ovarian cancer. This study was...
A clinical trial found hysteroscopic resection may improve outcomes for progestin-resistant atypical hyperplasia or grade 1 endometrial cancer in select patients. This study was presented at the Society of...
A pilot study from the University of Pennsylvania has found that a simple electronic nudge embedded in the electronic health record increased referrals to gynecologic oncology for patients with suspected...
Real-world data show a rise in biomarker testing for primary advanced/recurrent endometrial cancer, especially mismatch repair/microsatellite instability, but disparities in access persist across care...
A retrospective cohort study found that endometrial biopsies identifying endometrial intraepithelial neoplasia were associated with a higher likelihood of endometrial cancer and high-risk features on final...
A study identified biomarkers associated with response and resistance to nivolumab plus cabozantinib in recurrent endometrial cancer, offering insights for future therapies.
A randomized trial found a minor overall survival benefit for robotic-assisted laparoscopy over coheanventional laparoscopy in endometrial cancer treatment.
